One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.

摘要

The guidelines for the management of patients with thyroid nodules and differentiated thyroid carcinoma (DTC) recently published by the American Thyroid Association (ATA) [1] represent a valuable, comprehensive resource for the clinician. These guidelines contain 80 recommendations based on 434 cited references and on the knowledge and experience of an impressive roster of not just American but also European experts.